{"version":"1.0","type":"link","title":"Targeting RSK2 enhances the efficacy of IGF1R inhibitor against triple-negative breast cancer via antagonizing IGF1/IGF1R signaling mediated by GATA3-IGFBP5 pathway.","author_name":"Shan TJ 외","author_url":"https://prs-insight.online/author/Shan%20TJ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/75384","thumbnail_width":1200,"thumbnail_height":630}